BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

250 related articles for article (PubMed ID: 16759669)

  • 1. Is ferroportin-hepcidin signaling altered in restless legs syndrome?
    Clardy SL; Wang X; Boyer PJ; Earley CJ; Allen RP; Connor JR
    J Neurol Sci; 2006 Sep; 247(2):173-9. PubMed ID: 16759669
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MRI-determined regional brain iron concentrations in early- and late-onset restless legs syndrome.
    Earley CJ; B Barker P; Horská A; Allen RP
    Sleep Med; 2006 Aug; 7(5):458-61. PubMed ID: 16740411
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Thy1 expression in the brain is affected by iron and is decreased in Restless Legs Syndrome.
    Wang X; Wiesinger J; Beard J; Felt B; Menzies S; Earley C; Allen R; Connor J
    J Neurol Sci; 2004 May; 220(1-2):59-66. PubMed ID: 15140607
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ferritin subunits in CSF are decreased in restless legs syndrome.
    Clardy SL; Earley CJ; Allen RP; Beard JL; Connor JR
    J Lab Clin Med; 2006 Feb; 147(2):67-73. PubMed ID: 16459164
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Does the endogenous opiate system play a role in the Restless Legs Syndrome? A pilot post-mortem study.
    Walters AS; Ondo WG; Zhu W; Le W
    J Neurol Sci; 2009 Apr; 279(1-2):62-5. PubMed ID: 19167016
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Restless legs syndrome: pathophysiology and the role of iron and folate.
    Patrick LR
    Altern Med Rev; 2007 Jun; 12(2):101-12. PubMed ID: 17604457
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Profile of altered brain iron acquisition in restless legs syndrome.
    Connor JR; Ponnuru P; Wang XS; Patton SM; Allen RP; Earley CJ
    Brain; 2011 Apr; 134(Pt 4):959-68. PubMed ID: 21398376
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Decreased transferrin receptor expression by neuromelanin cells in restless legs syndrome.
    Connor JR; Wang XS; Patton SM; Menzies SL; Troncoso JC; Earley CJ; Allen RP
    Neurology; 2004 May; 62(9):1563-7. PubMed ID: 15136682
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Restless-legs syndrome].
    Karroum E; Konofal E; Arnulf I
    Rev Neurol (Paris); 2008; 164(8-9):701-21. PubMed ID: 18656214
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hepcidin regulates cellular iron efflux by binding to ferroportin and inducing its internalization.
    Nemeth E; Tuttle MS; Powelson J; Vaughn MB; Donovan A; Ward DM; Ganz T; Kaplan J
    Science; 2004 Dec; 306(5704):2090-3. PubMed ID: 15514116
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The treatment of restless legs syndrome with intravenous iron dextran.
    Earley CJ; Heckler D; Allen RP
    Sleep Med; 2004 May; 5(3):231-5. PubMed ID: 15165528
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CSF iron, ferritin and transferrin levels in restless legs syndrome.
    Mizuno S; Mihara T; Miyaoka T; Inagaki T; Horiguchi J
    J Sleep Res; 2005 Mar; 14(1):43-7. PubMed ID: 15743333
    [TBL] [Abstract][Full Text] [Related]  

  • 13. T2 relaxometry and fMRI of the brain in late-onset restless legs syndrome.
    Astrakas LG; Konitsiotis S; Margariti P; Tsouli S; Tzarouhi L; Argyropoulou MI
    Neurology; 2008 Sep; 71(12):911-6. PubMed ID: 18794493
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Diagnosis and symptom rating scale of restless legs syndrome].
    Inoue Y
    Brain Nerve; 2009 May; 61(5):533-8. PubMed ID: 19514513
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neuropathological examination suggests impaired brain iron acquisition in restless legs syndrome.
    Connor JR; Boyer PJ; Menzies SL; Dellinger B; Allen RP; Ondo WG; Earley CJ
    Neurology; 2003 Aug; 61(3):304-9. PubMed ID: 12913188
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multiregional brain iron deficiency in restless legs syndrome.
    Godau J; Klose U; Di Santo A; Schweitzer K; Berg D
    Mov Disord; 2008 Jun; 23(8):1184-7. PubMed ID: 18442125
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pro-hepcidin is unable to degrade the iron exporter ferroportin unless maturated by a furin-dependent process.
    Gagliardo B; Kubat N; Faye A; Jaouen M; Durel B; Deschemin JC; Canonne-Hergaux F; Sari MA; Vaulont S
    J Hepatol; 2009 Feb; 50(2):394-401. PubMed ID: 19070914
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epidemiology and clinical findings of restless legs syndrome.
    Zucconi M; Ferini-Strambi L
    Sleep Med; 2004 May; 5(3):293-9. PubMed ID: 15165538
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The severity range of restless legs syndrome (RLS) and augmentation in a prospective patient cohort: association with ferritin levels.
    Frauscher B; Gschliesser V; Brandauer E; El-Demerdash E; Kaneider M; Rücker L; Poewe W; Högl B
    Sleep Med; 2009 Jun; 10(6):611-5. PubMed ID: 19200780
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical characteristics of Restless legs syndrome in patients with Parkinson's disease.
    Nomura T; Inoue Y; Nakashima K
    J Neurol Sci; 2006 Dec; 250(1-2):39-44. PubMed ID: 16899256
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.